1,489
Views
17
CrossRef citations to date
0
Altmetric
Report

An integrative analysis of reprogramming in human isogenic system identified a clone selection criterion

, , , , , , , & show all
Pages 986-997 | Received 05 Oct 2015, Accepted 04 Feb 2016, Published online: 26 Feb 2016

References

  • Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282:1145-7; PMID:9804556; http://dx.doi.org/10.1126/science.282.5391.1145
  • Pan CK, Heilweil G, Lanza R, Schwartz SD. Embryonic stem cells as a treatment for macular degeneration. Expert Opin Biol Ther 2013; 13:1125-33; PMID:23705996; http://dx.doi.org/10.1517/14712598.2013.793304
  • Schwartz SD, Hubschman J-P, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012; 379:713-20; PMID:22281388; http://dx.doi.org/10.1016/S0140-6736(12)60028-2
  • Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD, Ziller M, Croft GF, Amoroso MW, Oakley DH, et al. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 2011; 144:439-52; PMID:21295703; http://dx.doi.org/10.1016/j.cell.2010.12.032
  • Marchetto MCN, Yeo GW, Kainohana O, Marsala M, Gage FH, Muotri AR. Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 2009; 4:e7076; PMID:19763270; http://dx.doi.org/10.1371/journal.pone.0007076
  • Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J, et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009; 5:111-23; PMID:19570518; http://dx.doi.org/10.1016/j.stem.2009.06.008
  • Ohi Y, Qin H, Hong C, Blouin L, Polo JM, Guo T, Qi Z, Downey SL, Manos PD, Rossi DJ, et al. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol 2011; 13:541-9; PMID:21499256; http://dx.doi.org/10.1038/ncb2239
  • Stadtfeld M, Apostolou E, Akutsu H, Fukuda A, Follett P, Natesan S, Kono T, Shioda T, Hochedlinger K. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010; 465:175-81; PMID:20418860; http://dx.doi.org/10.1038/nature09017
  • Nostro MC, Keller G. Generation of beta cells from human pluripotent stem cells: Potential for regenerative medicine. Semin Cell Dev Biol 2012; 23:701-10; PMID:22750147; http://dx.doi.org/10.1016/j.semcdb.2012.06.010
  • Atala A, Kasper FK, Mikos AG. Engineering complex tissues. Sci Transl Med 2012; 4:160rv12; http://dx.doi.org/10.1126/scitranslmed.3004890
  • Tedesco FS, Gerli MFM, Perani L, Benedetti S, Ungaro F, Cassano M, Antonini S, Tagliafico E, Artusi V, Longa E, et al. Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. Sci Transl Med 2012; 4:140ra89; PMID:22745439; http://dx.doi.org/10.1126/scitranslmed.3003541
  • Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, Apostolou E, Stadtfeld M, Li Y, Shioda T, et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010; 28:848-55; PMID:20644536; http://dx.doi.org/10.1038/nbt.1667
  • Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011; 470:68-73; http://dx.doi.org/10.1038/nature09798
  • Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LIR, et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010; 467:285-90; PMID:20644535; http://dx.doi.org/10.1038/nature09342
  • Ruiz S, Panopoulos AD, Montserrat N, Multon MC, Daury A, Rocher C, Spanakis E, Batchelder EM, Orsini C, Deleuze JF, et al. Generation of a drug-inducible reporter system to study cell reprogramming in human cells. J Biol Chem 2012; 287:40767-78; PMID:23019325; http://dx.doi.org/10.1074/jbc.M112.384024
  • Nazor KL, Altun G, Lynch C, Tran H, Harness JV, Slavin I, Garitaonandia I, Müller F-J, Wang Y-C, Boscolo FS, et al. Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell 2012; 10:620-34; PMID:22560082; http://dx.doi.org/10.1016/j.stem.2012.02.013
  • Yamanaka S. Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 2012; 10:678-84; PMID:22704507; http://dx.doi.org/10.1016/j.stem.2012.05.005
  • Lagarkova MA, Volchkov PY, Lyakisheva AV, Philonenko ES, Kiselev SL. Diverse epigenetic profile of novel human embryonic stem cell lines. Cell Cycle 2006; 5:416-20; PMID:16479162; http://dx.doi.org/10.4161/cc.5.4.2440
  • International Stem Cell Initiative, Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB, et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 2011; 29:1132-44; PMID:22119741; http://dx.doi.org/10.1038/nbt.2051
  • Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 2010;42:1113-7; PMID:21057500; http://dx.doi.org/10.1038/ng.710
  • Wang XM, Yik WY, Zhang P, Lu W, Dranchak PK, Shibata D, Steinberg SJ, Hacia JG. The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesis. Stem Cell Res Ther 2012; 3:39; PMID:23036268; http://dx.doi.org/10.1186/scrt130
  • Murrell W, Palmero E, Bianco J, Stangeland B, Joel M, Paulson L, Thiede B, Grieg Z, Ramsnes I, Skjellegrind HK, et al. Expansion of multipotent stem cells from the adult human brain. PLoS One 2013; 8:e71334; PMID:23967194; http://dx.doi.org/10.1371/journal.pone.0071334
  • Zhang Z, Zhang Y, Xiao H, Liang X, Sun D, Peng S. A gene expression profile of the developing human retinal pigment epithelium. Molecular Vision 2012; 18:2961-75; PMID:23487591
  • Strunnikova NV, Maminishkis A, Barb JJ, Wang F, Zhi C, Sergeev Y, Chen W, Edwards AO, Stambolian D, Abecasis G, et al. Transcriptome analysis and molecular signature of human retinal pigment epithelium. Hum Mol Genet 2010; 19:2468-86; PMID:20360305; http://dx.doi.org/10.1093/hmg/ddq129
  • Booij JC, van Soest S, Swagemakers SM, Essing AH, Verkerk AJ, van der Spek PJ, Gorgels TG, Bergen AA. Functional annotation of the human retinal pigment epithelium transcriptome. BMC Genomics 2009; 10:164-178; PMID:19379482; http://dx.doi.org/10.1186/1471-2164-10-164
  • Bhatia S, Pilquil C, Roth-Albin I, Draper JS. Demarcation of stable subpopulations within the pluripotent hESC compartment. PLoS One 2013; 8:e57276; PMID:23437358; http://dx.doi.org/10.1371/journal.pone.0057276
  • Carey BW, Markoulaki S, Hanna JH, Faddah DA, Buganim Y, Kim J, Ganz K, Steine EJ, Cassady JP, Creyghton MP, et al. Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell 2011; 9:588-98; PMID:22136932; http://dx.doi.org/10.1016/j.stem.2011.11.003
  • Stelzer Y, Ronen D, Bock C, Boyle P, Meissner A, Benvenisty N. Identification of novel imprinted differentially methylated regions by global analysis of human-parthenogenetic-induced pluripotent stem cells. Stem Cell Reports 2013; 1:79-89; PMID:24052944; http://dx.doi.org/10.1016/j.stemcr.2013.03.005
  • Huang K, Shen Y, Xue Z, Bibikova M, April C, Liu Z, Cheng L, Nagy A, Pellegrini M, Fan J-B, et al. A Panel of CpG Methylation Sites Distinguishes Human Embryonic Stem Cells and Induced Pluripotent Stem Cells. Stem Cell Reports 2014; 2:36-43; PMID:24511466; http://dx.doi.org/10.1016/j.stemcr.2013.11.003
  • Mallon BS, Hamilton RS, Kozhich OA, Johnson KR, Fann YC, Rao MS, Robey PG. Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin. Stem Cell Res 2014; 12:376-86; PMID:24374290; http://dx.doi.org/10.1016/j.scr.2013.11.010
  • Assawachananont J, Mandai M, Okamoto S, Yamada C, Eiraku M, Yonemura S, Sasai Y, Takahashi M. Transplantation of embryonic and induced pluripotent stem cell-derived 3D retinal sheets into retinal degenerative mice. Stem Cell Reports 2014; 2:662-74; PMID:24936453; http://dx.doi.org/10.1016/j.stemcr.2014.03.011
  • Rouhani F, Kumasaka N, de Brito MC, Bradley A, Vallier L, Gaffney D. Genetic background drives transcriptional variation in human induced pluripotent stem cells. PLoS Genet 2014; 10:e1004432; PMID:24901476; http://dx.doi.org/10.1371/journal.pgen.1004432
  • Stadtfeld M, Apostolou E, Ferrari F, Choi J, Walsh RM, Chen T, Ooi SSK, Kim SY, Bestor TH, Shioda T, et al. Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nat Genet 2012; 44:398-405; PMID:22387999; http://dx.doi.org/10.1038/ng.1110
  • Ichida JK, TCW J, Williams LA, Carter AC, Shi Y, Moura MT, Ziller M, Singh S, Amabile G, Bock C, et al. Notch inhibition allows oncogene-independent generation of iPS cells. Nat Chem Biol 2014; 10:632-9; PMID:24952596; http://dx.doi.org/10.1038/nchembio.1552
  • Tonge PD, Corso AJ, Monetti C, Hussein SMI, Puri MC, Michael IP, Li M, Lee D-S, Mar JC, Cloonan N, et al. Divergent reprogramming routes lead to alternative stem-cell states. Nature 2014; 516:192-7; PMID:25503232; http://dx.doi.org/10.1038/nature14047
  • Boulting GL, Kiskinis E, Croft GF, Amoroso MW, Oakley DH, Wainger BJ, Williams DJ, Kahler DJ, Yamaki M, Davidow L, et al. A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol 2011; 29:279-86; PMID:21293464; http://dx.doi.org/10.1038/nbt.1783
  • Daley GQ, Lensch MW, Jaenisch R, Meissner A, Plath K, Yamanaka S. Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell 2009; 4:200-1; PMID:19265657; http://dx.doi.org/10.1016/j.stem.2009.02.009
  • Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2006; 8:118-27; PMID:16632515; http://dx.doi.org/10.1093/biostatistics/kxj037
  • Touleimat N, Tost J. Complete pipeline for Infinium(→) Human Methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation. Epigenomics 2012; 4:325-41; PMID:22690668; http://dx.doi.org/10.2217/epi.12.21
  • McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 2010; 28:495-501; PMID:20436461; http://dx.doi.org/10.1038/nbt.1630
  • Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 2009; 10:48; PMID:19192299; http://dx.doi.org/10.1186/1471-2105-10-48
  • Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res 2013; 41:W77-83; PMID:23703215; http://dx.doi.org/10.1093/nar/gkt439

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.